封面
市场调查报告书
商品编码
1941779

麻醉设备市场规模、份额和趋势分析报告:按产品、最终用途、地区和细分市场预测,2026-2033年

Anesthesia Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2026 - 2033

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

麻醉设备市场概述

全球麻醉设备市场预计到 2025 年将价值 246 亿美元,预计到 2033 年将达到 303 亿美元。

预计从 2026 年到 2033 年,该市场将以 2.26% 的复合年增长率成长。市场成长的驱动因素包括全球外科手术数量的增加、慢性疾病的流行以及麻醉工作站显示器的技术进步。

主要製造商经常推出新产品和改进现有产品,加速了儿童和手术中心对技术应用和升级的需求,推动了麻醉设备产业的成长。主要企业不断推出新一代麻醉工作站,这些工作站具备增强的安全功能、先进的通气模式、更符合人体工学的设计、数位整合以及对永续性的重视,以满足成人、儿科和新生儿护理中不断变化的临床需求。例如:

  • 2025 年 10 月,GE 医疗在 2025 年麻醉学大会上推出了 Carestation 850 麻醉输送系统,该系统采用符合人体工学的设计、可自订的应用程式、先进的汽化功能、永续性工具和直觉的用户介面,旨在提高从新生儿到成人等各种患者的精准度和效率。

「在瞬息万变的外科手术环境中,麻醉专业人员需要应对日益复杂的病例和不断变化的患者需求,同时始终将安全放在首位。随着麻醉护理团队面临新的挑战,技术可以帮助减轻他们的负担,并提供更安全、更有效的护理。”

约翰·比尔德医学博士,通用电气医疗集团患者照护解决方案首席医疗官;麻醉师

  • 2025年9月,Medicis在德里国际医疗展上发布了印度製造的COSMOS麻醉工作站。该工作站配备了新生儿专用技术,例如15英寸先进介面、整合式病患监测和LED照光治疗。产品设计以病人安全、临床操作便利性和环境效率为首要考量。

这些持续的创新正在扩大麻醉设备的临床应用范围,帮助其符合更严格的安全性和效率标准,并鼓励医疗保健提供者升级旧系统,从而推动整体市场成长和对先进麻醉工作站的长期需求。

麻醉设备市场的一个显着新兴趋势是人工智慧 (AI) 和智慧软体的融合,这正在改变麻醉护理的模式。人工智慧演算法支援智慧通气管理,能够利用即时患者数据优化麻醉气体输送,透过预测性警报预测不利事件,并透过自动化和决策支援减轻医护人员的认知负荷。

这些功能还有助于提高工作流程效率,实现成人、儿童和新生儿护理的标准化,并增强与手术全期IT系统的互通性。例如,2026年1月,GE医疗与恩智浦半导体合作,共同开发急诊的边缘人工智慧解决方案。这些解决方案在2026年国际消费电子展(CES 2026)上展出,包括语音活化麻醉管理系统(可减轻医护人员的认知负荷)和用于新生儿加护病房(NICU)的即时新生儿监护系统。此次合作充分利用了恩智浦的安全边缘处理器和GE医疗的医疗技术专长,在手术室和其他先进医疗环境中实现了低延迟、注重隐私的人工智慧。人工智慧的日益普及使麻醉设备更加智慧、安全和高效,加速了先进麻醉系统在现代医疗机构中的应用。

目录

第一章调查方法和范围

第二章执行摘要

第三章 麻醉设备市场变数、趋势与范围

  • 市场动态
  • 麻醉设备市场分析工具
    • 产业分析:波特五力模型
    • PESTEL 分析

第四章 麻醉设备市场:依产品分類的估算与趋势分析

  • 按产品类型分類的市场份额(2025 年和 2033 年)
  • 全球麻醉设备市场:按产品类型分類的展望
  • 麻醉机
    • 麻醉工作站
    • 麻醉输送装置
    • 麻醉人工呼吸器
    • 麻醉监控器
  • 麻醉耗材
    • 麻醉面罩
    • 麻醉配件

第五章 麻醉设备市场:依最终用途分類的估算与趋势分析

  • 按最终用途分類的市场份额(2025 年和 2033 年)
  • 全球麻醉设备市场:按最终用途分類的展望
  • 医院
  • 门诊治疗中心
  • 其他的

第六章:麻醉设备市场:区域估算与趋势分析

  • 区域市场占有率分析(2025 年和 2033 年)
  • 区域市场概览
  • 全球市场概览(按地区划分)
  • 市场规模及预测趋势分析,2021-2033年
  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争情势

  • 对主要市场参与企业近期趋势和影响的分析
  • 公司/竞争对手分类
  • 主要企业市占率和地位分析(2025 年)
  • 公司简介
    • GE Healthcare
    • Dragerwerk AG &Co. KGaA
    • Mindray Bio-Medical Electronics Co., Ltd.
    • Medtronic
    • Koninklijke Philips NV
    • Beijing Aeonmed Co., Ltd.
    • Spacelabs Healthcare acquired by OSI Systems, Inc.
    • Getinge AB
    • Penlon
    • Heal Force Bio-Meditech Holdings Limited
    • Shenzhen Northern Meditec Limited
    • Shanghai Huifeng Medical Instrument Co., Ltd.
    • Shenzhen Comen Medical Instruments Co., Ltd.
    • BPL Medical Technologies
    • aXcent medical
Product Code: GVR-4-68040-841-4

Anesthesia Devices Market Summary

The global anesthesia devices market size was estimated at USD 24.6 billion in 2025 and is projected to reach USD 30.3 billion by 2033, growing at a CAGR of 2.26% from 2026 to 2033. The market growth is driven by the increasing number of surgical procedures worldwide, the prevalence of chronic diseases, and technological advancements in anesthesia workstations and monitors

Increasing frequency of new and upgraded product launches by leading manufacturers is accelerating technology adoption and replacement demand across hospitals and surgical centers, contributing to the growth of the anesthesia machines industry. Major players are continuously introducing next-generation anesthesia workstations with enhanced safety features, advanced ventilation modes, improved ergonomics, digital integration, and sustainability-focused designs, addressing evolving clinical requirements across adult, pediatric, and neonatal care. For instance:

  • In October 2025, GE HealthCare launched the Carestation 850 anesthesia delivery system at ANESTHESIOLOGY 2025, featuring ergonomic design, customizable apps, advanced vaporization, sustainability tools, and intuitive UI to enhance precision and efficiency for diverse patients from neonates to adults.

"In the dynamic operating environment, anesthesia professionals are focused on safety while managing increasingly complex cases and changing patient needs. As anesthesia care teams face new challenges, technology can help ease the burden and support safer and more effective care delivery."

John Beard, MD, anesthesiologist and Chief Medical Officer of Patient Care Solutions at GE HealthCare.

  • In September 2025, Medisys launched the Made-in-India COSMOS anesthesia workstation, featuring a 15-inch advanced interface, integrated patient monitoring, and neonatal technology such as LED Phototherapy, at Medicall Delhi. This launch prioritized patient safety, clinician usability, and eco-friendly efficiency.

Such continuous innovation expands the clinical applicability of anesthesia machines, supports compliance with stricter safety and efficiency standards, and encourages healthcare providers to upgrade legacy systems, thereby strongly driving overall market growth and long-term demand for advanced anesthesia workstations.

A significant emerging trend in the anesthesia devices market is the integration of artificial intelligence (AI) and smart software, which is transforming the delivery of anesthesia care. AI-enabled algorithms support intelligent ventilation management, optimize anesthetic gas delivery using real-time patient data, enable predictive alarms to anticipate adverse events, and reduce clinician cognitive burden through automation and decision support.

These capabilities also improve workflow efficiency, standardize care across adult, pediatric, and neonatal populations, and enhance interoperability with perioperative IT systems. For instance, in January 2026, GE HealthCare collaborated with NXP Semiconductors to develop edge AI solutions for acute care, including voice-activated anesthesia delivery systems to reduce clinician cognitive load and real-time neonatal monitoring for NICUs, showcased at CES 2026; the partnership leverages NXP's secure edge processors and GE HealthCare's medical technology expertise to deliver low-latency, privacy-focused AI in operating rooms and other high-acuity settings. Thus, the growing integration of AI is making anesthesia devices smarter, safer, and more efficient, thereby accelerating the adoption of advanced anesthesia systems across modern healthcare facilities.

Global Anesthesia Devices Market Report Segmentation

This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global anesthesia devices market report based on product, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Anesthesia Machines
    • Anesthesia Workstation
    • Anesthesia delivery machines
    • Portable
    • Standalone
    • Anesthesia Ventilators
    • Anesthesia Monitors
  • Anesthesia Disposables
    • Anesthesia Masks
    • Anesthesia Accessories
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Ambulatory Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product outlook
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline.
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Anesthesia Devices Market Variables, Trends & Scope

  • 3.1. Market Dynamics
    • 3.1.1. Market Driver analysis
      • 3.1.1.1. Increasing number of surgical procedures worldwide
      • 3.1.1.2. Rising prevalence of chronic diseases requiring surgery
      • 3.1.1.3. Growth of ambulatory surgery and day-care centers
      • 3.1.1.4. Technological advancements in anesthesia workstations and monitors
    • 3.1.2. Market Restraint Analysis
      • 3.1.2.1. High capital cost of advanced anesthesia workstations
      • 3.1.2.2. High maintenance and servicing costs
    • 3.1.3. Market Opportunities
    • 3.1.4. Market Challenges
    • 3.1.5. Emerging Trends
  • 3.2. Anesthesia Devices Market Analysis Tools
    • 3.2.1. Industry Analysis - Porter's
      • 3.2.1.1. Supplier power
      • 3.2.1.2. Buyer power
      • 3.2.1.3. Substitution threat
      • 3.2.1.4. Threat of new entrant
      • 3.2.1.5. Competitive rivalry
    • 3.2.2. PESTEL Analysis
      • 3.2.2.1. Political landscape
      • 3.2.2.2. Economic landscape
      • 3.2.2.3. Social landscape
      • 3.2.2.4. Technological landscape
      • 3.2.2.5. Environmental landscape
      • 3.2.2.6. Legal landscape

Chapter 4. Anesthesia Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Type Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Anesthesia Devices Market by Product Type Outlook
  • 4.4. Anesthesia Machines
    • 4.4.1. Anesthesia Machines market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Anesthesia Workstation
      • 4.4.2.1. Anesthesia Workstation market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Anesthesia Delivery Machines
      • 4.4.3.1. Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Portable Anesthesia Delivery Station
        • 4.4.3.2.1. Portable Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Standalone Anesthesia Delivery Station
        • 4.4.3.3.1. Standalone Anesthesia Delivery Machines market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Anesthesia Ventilators
      • 4.4.4.1. Anesthesia Ventilators market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.5. Anesthesia Monitors
      • 4.4.5.1. Anesthesia Monitors market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Anesthesia Disposables
    • 4.5.1. Anesthesia Disposables market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Anesthesia Masks
      • 4.5.2.1. Anesthesia Masks market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Anesthesia Accessories
      • 4.5.3.1. Anesthesia Accessories market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Anesthesia Devices Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Type Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Anesthesia Devices Market by End Use Outlook
  • 5.4. Hospitals
    • 5.4.1. Hospitals' market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ambulatory Centers
    • 5.5.1. Ambulatory Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Anesthesia Devices Market: Regional Estimates & Trend Analysis, By Product & End Use

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Key company market share/position analysis, 2025
  • 7.4. Company Profiles
    • 7.4.1. GE Healthcare
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Dragerwerk AG & Co. KGaA
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Mindray Bio-Medical Electronics Co., Ltd.
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Koninklijke Philips N.V.
      • 7.4.5.1. Company Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Beijing Aeonmed Co., Ltd.
      • 7.4.6.1. Company Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Spacelabs Healthcare acquired by OSI Systems, Inc.
      • 7.4.7.1. Company Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Getinge AB
      • 7.4.8.1. Company Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Penlon
      • 7.4.9.1. Company Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Heal Force Bio-Meditech Holdings Limited
      • 7.4.10.1. Company Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic initiatives
    • 7.4.11. Shenzhen Northern Meditec Limited
      • 7.4.11.1. Company Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Strategic initiatives
    • 7.4.12. Shanghai Huifeng Medical Instrument Co., Ltd.
      • 7.4.12.1. Company Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Strategic initiatives
    • 7.4.13. Shenzhen Comen Medical Instruments Co., Ltd.
      • 7.4.13.1. Company Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Strategic initiatives
    • 7.4.14. BPL Medical Technologies
      • 7.4.14.1. Company Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Strategic initiatives
    • 7.4.15. aXcent medical
      • 7.4.15.1. Company Overview
      • 7.4.15.2. Financial Performance
      • 7.4.15.3. Product Benchmarking
      • 7.4.15.4. Strategic initiatives

List of Tables

  • Table 1 North America Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 2 North America Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 3 North America Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 4 U.S. Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 5 U.S. Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 6 Canada Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 7 Canada Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 8 Mexico Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 9 Mexico Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 10 Europe Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 11 Europe Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 12 Europe Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 UK Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 UK Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 15 Germany Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 16 Germany Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 France Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 France Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 19 Italy Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 20 Italy Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Spain Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Spain Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 23 Sweden Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 24 Sweden Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Denmark Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 26 Denmark Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 27 Norway Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 28 Norway Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 32 China Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 33 China Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Japan Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Japan Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 36 India Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 37 India Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 Australia Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 Australia Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 40 South Korea Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 41 South Korea Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Thailand Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Thailand Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 44 Latin America Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 45 Latin America Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 46 Latin America Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 47 Brazil Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 48 Brazil Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 49 Argentina Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 50 Argentina Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 51 MEA Anesthesia Devices Market, By Region, 2021 - 2033 (USD Million)
  • Table 52 MEA Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 53 MEA Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 South Africa Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 South Africa Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 56 Saudi Arabia Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 UAE Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 UAE Anesthesia Devices Market, By End Use, 2021 - 2033 (USD Million)
  • Table 60 Kuwait Anesthesia Devices Market, By Product, 2021 - 2033 (USD Million)
  • Table 61 Kuwait Devices Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Aesthesia devices market outlook
  • Fig. 9 Aesthesia devices competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Aesthesia devices market driver impact
  • Fig. 15 Aesthesia devices market restraint impact
  • Fig. 16 Aesthesia devices market strategic initiatives analysis
  • Fig. 17 Aesthesia devices market: Product movement analysis
  • Fig. 18 Aesthesia devices market: Product outlook and key takeaways
  • Fig. 19 Anesthesia machines market, 2021 - 2033 (USD Million)
  • Fig. 20 Anesthesia delivery machines market, 2021 - 2033 (USD Million)
  • Fig. 21 Anesthesia monitors market, 2021 - 2033 (USD Million)
  • Fig. 22 Anesthesia ventilators market, 2021 - 2033 (USD Million)
  • Fig. 23 Anesthesia workstations market, 2021 - 2033 (USD Million)
  • Fig. 24 Anesthesia disposables market, 2021 - 2033 (USD Million)
  • Fig. 25 Anesthesia disposables masks market, 2021 - 2033 (USD Million)
  • Fig. 26 Anesthesia disposable accessories market, 2021 - 2033 (USD Million)
  • Fig. 27 Aesthesia devices market: End Use movement analysis
  • Fig. 28 Aesthesia devices market: End Use outlook and key takeaways
  • Fig. 29 Hospitals market, 2021 - 2033 (USD Million)
  • Fig. 30 Ambulatory Centers market, 2021 - 2033 (USD Million)
  • Fig. 31 Others market, 2021 - 2033 (USD Million)
  • Fig. 32 Global aesthesia devices market: Regional movement analysis
  • Fig. 33 Global aesthesia devices market: Regional outlook and key takeaways
  • Fig. 34 Global anesthesia devices market share and leading players
  • Fig. 35 North America market share and leading players
  • Fig. 36 Europe market share and leading players
  • Fig. 37 Asia Pacific market share and leading players
  • Fig. 38 Latin America market share and leading players
  • Fig. 39 Middle East & Africa market share and leading players
  • Fig. 40 North America market estimates and forecasts, 2021 - 2033
  • Fig. 41 U.S. market estimates and forecasts, 2021 - 2033
  • Fig. 42 Canada market estimates and forecasts, 2021 - 2033
  • Fig. 43 Mexico market estimates and forecasts, 2021 - 2033
  • Fig. 44 Europe market estimates and forecasts, 2021 - 2033
  • Fig. 45 UK market estimates and forecasts, 2021 - 2033
  • Fig. 46 Germany market estimates and forecasts, 2021 - 2033
  • Fig. 47 France market estimates and forecasts, 2021 - 2033
  • Fig. 48 Italy market estimates and forecasts, 2021 - 2033
  • Fig. 49 Spain market estimates and forecasts, 2021 - 2033
  • Fig. 50 Denmark market estimates and forecasts, 2021 - 2033
  • Fig. 51 Sweden market estimates and forecasts, 2021 - 2033
  • Fig. 52 Norway market estimates and forecasts, 2021 - 2033
  • Fig. 53 Asia Pacific market estimates and forecasts, 2021 - 2033
  • Fig. 54 China market estimates and forecasts, 2021 - 2033
  • Fig. 55 Japan market estimates and forecasts, 2021 - 2033
  • Fig. 56 India market estimates and forecasts, 2021 - 2033
  • Fig. 57 Thailand market estimates and forecasts, 2021 - 2033
  • Fig. 58 South Korea market estimates and forecasts, 2021 - 2033
  • Fig. 59 Australia market estimates and forecasts, 2021 - 2033
  • Fig. 60 Latin America market estimates and forecasts, 2021 - 2033
  • Fig. 61 Brazil market estimates and forecasts, 2021 - 2033
  • Fig. 62 Argentina market estimates and forecasts, 2021 - 2033
  • Fig. 63 Middle East and Africa market estimates and forecasts, 2021 - 2033
  • Fig. 64 South Africa market estimates and forecasts, 2021 - 2033
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2021 - 2033
  • Fig. 66 UAE market estimates and forecasts, 2021 - 2033
  • Fig. 67 Kuwait market estimates and forecasts, 2021 - 2033
  • Fig. 68 Market share of key market players- aesthesia devices market
  • Fig. 69 Key Company Categorization
  • Fig. 70 Company Market Share/Position Analysis, 2025
  • Fig. 71 Strategic Framework